RxDoctor Payments Data

Chonghua Wang, MD

Interventional Pain Medicine · Riverside, CANPI 1760748859

Payments from drug & device makers

$3,086in general payments, 2019–2025

Across 53 payments — averaging $58.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$539
  • Nevro Corp.$329
  • Abbott$189
  • Si-bone, Inc.$160
  • Electronic Waveform Lab, Inc.$64
  • plus $158 from 5 others

What the payments were for

  • Speaking & faculty fees$1,00032%
  • Food & beverage$2,08668%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific18$1,647
Medtronic(2 entities)10$539
Nevro Corp.4$329
Abbott7$189
Si-bone, Inc.6$160
Electronic Waveform Lab, Inc.1$64
Bioventus LLC2$58
Vertiflex, Inc.1$43
Biotronik NRO, Inc.2$29
Lundbeck LLC1$16
Johnson & Johnson1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,086 in reported general payments places this provider in the 45th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California

Medicare billing

Part B allowed, 2024
$149,192
Medicare patients
136
Services billed
4,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen553$13,406
Fentanyl36$5,423
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen105$2,908
Acetaminophen-CodeineAcetaminophen With Codeine128$2,512
Buprenorphine16$2,058
Lidocaine17$1,625
Gabapentin129$1,550
Pregabalin106$1,533
Tramadol Hcl154$1,437
Tramadol Hcl ErTramadol Hcl14$784
Diclofenac Sodium32$746
Celecoxib31$667
Tizanidine Hcl66$518
Methocarbamol33$517
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$478

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →